PDCA管理模式对白血病患者健康知识掌握程度及生活质量的影响

目的 探讨持续质量改进管理模式对白血病患者健康知识掌握程度和生活质量的影响。方法 根据入院日期，将2012年的104例和2013年的103例急性白血病患者分别纳入对照组和实验组，对照组给予常规管理模式，实验组在常规管理模式的基础上给予持续质量改进管理模式，比较2组患者健康知识掌握程度、生活质量功能、生活质量症状、护理满意度及住院时间的差异。结果 干预后，生活质量量表（quality of life questionnaire，QLQ-C30）功能评分均高于对照组（均有P<0.05），除经济困难外，QLQ-C30症状评分实验组各指标评分均低于对照组（均有P<0.05）；干预后，实验组患者健康知识掌握合格率、患者满意率均优于对照组（均有P<0.05），平均住院天数少于对照组，两组差异有统计学意义（t=13.78,P<0.001）。结论 应用持续质量改进管理模式能缩短患者住院时间，提高护理满意度和患者生活质量，应加强其在白血病护理工作中的推广应用。

Effect of continuous quality improvement PDCA management mode on health knowledge acquisition mastering and the quality of life of patients with leukemia

Objective To investigate the effects of continuous quality improvement management model on health knowledge acquisition mastering and the quality of life of patients with leukemia. Methods According to the date of hospitalization,104 cases (admitted in the year of 2012) and 103 cases (admitted in 2013) of leukemia patients, who were admitted to our department in the year of 2012 and 2013, respectively, were included in the control group and the experimental group, respectively. The control group received conventional care management while the experimental group received continuous quality improvement care management. The degree of health knowledge acquisition, quality of life, satisfaction with medical care and hospitalization time were compared between two groups. Results QLQ-C30 functional scores were higher and QLQ-C30 symptom scores lower in the experimental group compared to the control group, with statistical significance (all P<0.05). The degree of health knowledge acquisition and satisfaction with medical care in the experimental group is higher than the control group (all P<0.05). The average hospitalization days was lower in the experimental group compared to the control group. The difference was statistically significant (t=13.78,P<0.001). Conclusions Continuous quality improvement model can decrease the duration of hospitalization and increase the degree of satisfaction and quality of life of leukemia patients. Therefore, continuous quality improvement model should be widely applied in medical care of leukemia patients.